Literature DB >> 3966647

Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results.

M J Greenall, S H Quan, M W Stearns, C Urmacher, J J DeCosse.   

Abstract

Epidermoid cancer of the anal margin should be distinguished from that in the canal because of its different clinical and pathologic characteristics, the suitability of local excision for its treatment, and its better overall prognosis. In addition, margin cancer rarely metastasises to visceral sites. Forty-eight patients with epidermoid cancer of the anal margin were reviewed. Two refused treatment, 4 had palliative therapy for advanced, inoperable disease, 31 had local excision, and 11 were treated by abdominoperineal resection. Local excision provided satisfactory results with a corrected 5 year survival of 88 percent, although locoregional recurrence developed in 46 percent of these patients during follow-up. A second local excision or inguinal lymphadenectomy provided good results in the patients with recurrence. Abdominoperineal resection did not provide better overall survival figures.

Entities:  

Mesh:

Year:  1985        PMID: 3966647     DOI: 10.1016/s0002-9610(85)80016-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

1.  Clinical trials in the management of anal cancer.

Authors:  Sherjeel Sana; Aziz U Khan
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 2.  So Now My Patient Has Squamous Cell Cancer: Diagnosis, Staging, and Treatment of Squamous Cell Carcinoma of the Anal Canal and Anal Margin.

Authors:  Cindy Kin
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

3.  Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience.

Authors:  Olivier Chapet; Jean-Pierre Gerard; Francoise Mornex; Silvia Goncalves-Tavan; Jean-Michel Ardiet; Anne D'hombres; Veronique Favrel; Pascale Romestaing
Journal:  Int J Colorectal Dis       Date:  2006-03-31       Impact factor: 2.571

4.  Malignancies of the anal canal.

Authors:  I Lintzeris; X Agrogianni; P Prigouris; A Lintzeri; K Giovannakis; T Argyrakos; I Rodoyianni; S Prigouris
Journal:  Tech Coloproctol       Date:  2011-10       Impact factor: 3.781

5.  Management of anal epidermoid carcinoma--an evaluation of treatment results in two population-based series.

Authors:  S Goldman; B Glimelius; U Glas; G Lundell; L Påhlman; E Ståhle
Journal:  Int J Colorectal Dis       Date:  1989-12       Impact factor: 2.571

Review 6.  Treatment of primary epidermoid carcinoma of the anal canal.

Authors:  B J Cummings
Journal:  Int J Colorectal Dis       Date:  1987-06       Impact factor: 2.571

Review 7.  Changing nature of anal cancer.

Authors:  R W Talbot
Journal:  BMJ       Date:  1988-07-23

8.  Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report.

Authors:  Tercia Tarciane Sousa; Bruna do Nascimento Santos; Marcos Belotto; Renata D'Alpino Peixoto
Journal:  J Gastrointest Oncol       Date:  2016-12

9.  ACR Appropriateness Criteria®-Anal Cancer.

Authors:  Theodore S Hong; Jennifer L Pretz; Joseph M Herman; May Abdel-Wahab; Nilofer Azad; A William Blackstock; Prajnan Das; Karyn A Goodman; Salma K Jabbour; William E Jones; Andre A Konski; Albert C Koong; Miguel Rodriguez-Bigas; William Small; Charles R Thomas; Jennifer Zook; W Warren Suh
Journal:  Gastrointest Cancer Res       Date:  2014-01

Review 10.  Anal cancer treatment: current status and future perspectives.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Pamela Abdayem; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.